Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.
| Last: | $77.02 |
|---|---|
| Change Percent: | -3.03% |
| Open: | $79.13 |
| Close: | $79.425 |
| High: | $80.63 |
| Low: | $76.485 |
| Volume: | 229,380 |
| Last Trade Date Time: | 02/27/2026 12:43:26 pm |
| Market Cap: | $2,739,577,040 |
|---|---|
| Float: | 20,348,831 |
| Insiders Ownership: | 0.11% |
| Institutions: | 111 |
| Short Percent: | N/A |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.genedx.com |
| Country: | US |
| City: | Stamford |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about GeneDx Holdings Corp. (NASDAQ: WGS).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.